Fractionated Stereotactic Radiotherapy for Facial Nerve Schwannomas

Abstract

Purpose Data on the clinical course of irradiated facial nerve schwannomas (FNS) are lacking. We evaluated fractionated stereotactic radiotherapy (FSRT) for FNS.

Methods Eight consecutive patients with FNS treated at our institution between 1998 and 2011 were included. Patients were treated with FSRT to a median dose of 50.4 Gy (range: 46.8–54 Gy) in 1.8 or 2.0 Gy fractions. We report the radiographic response, symptom control, and toxicity associated with FSRT for FNS.

Results The median follow-up time was 43 months (range: 10–75 months). All patients presented with symptoms including pain, tinnitus, facial asymmetry, diplopia, and hearing loss. The median tumor volume was 1.57 cc. On the most recent follow-up imaging, five patients were noted to have stable tumor size; three patients had a net reduction in tumor volume. Additionally, six patients had improvement in clinical symptoms, one patient had stable clinical findings, and one patient had worsened House-Brackmann grade due to cystic degeneration.

Conclusion FSRT treatment of FNS results in excellent control of growth and symptoms with a small rate of radiation toxicity. Given the importance of maintaining facial nerve function, FSRT could be considered as a primary management modality for enlarging or symptomatic FNS.

Keywords

stereotactic radiotherapy - facial nerve schwannoma

• References

• 1 O'Donoghue GM, Brackmann DE, House JW, Jackler RK. Neuromas of the facial nerve. Am J Otol 1989; 10 (1) 49-54
• 2 Lipkin AF, Coker NJ, Jenkins HA, Alford BR. Intracranial and intratemporal facial neuroma. Otolaryngol H ead Neck Surg 1987; 96 (1) 71-79
• 3 Angeli SI, Brackmann DE. Is surgical excision of facial nerve schwannomas always indicated?. Otolaryngol Head Neck Surg 1997; 117 (6) S144-S147
• 4 Madorsky SJ, Swett JE, Crumley RL. Motor versus sensory neuron regeneration through collagen tubules. Plast Reconstr Surg 1998; 102 (2) 430-436 ; discussion 437–438
• 5 Liu R, Fagan P. Facial nerve schwannoma: surgical excision versus conservative management. Ann Otol Rhinol Laryngol 2001; 110 (11) 1025-1029
• 6 Arthurs BJ, Fairbanks RK, Demakas JJ , et al. A review of treatment modalities for vestibular schwannoma. Neurosurg Rev 2011; 34 (3) 265-277 ; discussion 277–279
• 7 Kida Y, Yoshimoto M, Hasegawa T. Radiosurgery for facial schwannoma. J Neurosurg 2007; 106 (1) 24-29
• 8 Mabanta SR, Buatti JM, Friedman WA, Meeks SL, Mendenhall WM, Bova FJ. Linear accelerator radiosurgery for nonacoustic schwannomas. Int J Radiat Oncol Biol Phys 1999; 43 (3) 545-548
• 9 Madhok R, Kondziolka D, Flickinger JC, Lunsford LD. Gamma knife radiosurgery for facial schwannomas. Neurosurgery 2009; 64 (6) 1102-1105 ; discussion 1105
• 10 McMonagle B, Al-Sanosi A, Croxson G, Fagan P. Facial schwannoma: results of a large case series and review. J Laryngol Otol 2008; 122 (11) 1139-1150
• 11 Chung JW, Ahn JH, Kim JH, Nam SY, Kim CJ, Lee KS. Facial nerve schwannomas: different manifestations and outcomes. Surg Neurol 2004; 62 (3) 245-252 ; discussion 452
• 12 Hasegawa T, Kobayashi T, Kida Y, Tanaka T, Yoshida K, Osuka K. Two cases of facial neurinoma successfully treated with gamma knife radiosurgery [in Japanese]. No Shinkei Geka 1999; 27 (2) 171-175
• 13 Isono N, Tamura Y, Kuroiwa T , et al. Combined therapy with surgery and stereotactic radiosurgery for facial schwannoma: case report [in Japanese]. No Shinkei Geka 2002; 30 (7) 735-739
• 14 Litre CF, Gourg GP, Tamura M , et al. Gamma knife surgery for facial nerve schwannomas. Neurosurgery 2007; 60 (5) 853-859 ; discussion 853–859
• 15 Nishioka K, Abo D, Aoyama H , et al. Stereotactic radiotherapy for intracranial nonacoustic schwannomas including facial nerve schwannoma. Int J Radiat Oncol Biol Phys 2009; 75 (5) 1415-1419
• 16 Showalter TN, Werner-Wasik M, Curran Jr WJ, Friedman DP, Xu X, Andrews DW. Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of nonacoustic cranial nerve schwannomas. Neurosurgery 2008; 63 (4) 734-740 ; discussion 740
• 17 Andrews DW, Suarez O, Goldman HW , et al. Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys 2001; 50 (5) 1265-1278
• 18 Shirato H, Sakamoto T, Sawamura Y , et al. Comparison between observation policy and fractionated stereotactic radiotherapy (SRT) as an initial management for vestibular schwannoma. Int J Radiat Oncol Biol Phys 1999; 44 (3) 545-550
• 19 Hillman TA, Chen DA, Fuhrer R. An alternative treatment for facial nerve tumors: short-term results of radiotherapy. Ear Nose Throat J 2008; 87 (10) 574-577
• 20 Champ CE, Shen X, Shi W , et al. Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: maintenance of tumor control with improved hearing preservation. Neurosurgery 2013; 73 (3) 489-496
• 21 Combs SE, Engelhard C, Kopp C , et al. Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas—pooled results from 3 large German centers. Radiother Oncol 2015; 114 (3) 378-383
• 22 Woolf DK, Williams M, Goh CL , et al. Fractionated stereotactic radiotherapy for acoustic neuromas: long-term outcomes. Clin Oncol (R Coll Radiol) 2013; 25 (12) 734-738